PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of August 10, 2026, PRCT trades at $20.32 with a market cap of $1.17B and a P/E ratio of -10.47. PRCT moved +1.85% today. Year to date, PRCT is -35.12%; over the trailing twelve months it is -48.45%. Its 52-week range spans $16.67 to $90.47. Analyst consensus is neutral with an average price target of $23.13. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PRCT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $20.32 |
| Market Cap | $1.17B |
| P/E Ratio | -10.47 |
| EPS | $-1.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $90.47 |
| 52-Week Low | $16.67 |
| Volume | 1.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $337.34M |
| Net Income | $-109.75M |
| Gross Margin | 64.22% |
11 analysts cover PRCT: 0 strong buy, 3 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $23.13.